COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS

Title:

COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS

Document Type and Number:

Japanese Patent JP2023123761

Kind Code:

A

Abstract:

To provide a hormone replacement therapy, associated compounds and associated packaging units, for alleviating menopause-associated symptoms.SOLUTION: A composition for use in alleviating menopause-associated symptoms comprises an estetrol component and is administered at a daily amount equivalent to about 15 mg to about 25 mg of estetrol. Optionally, a second composition comprising a progestogenic component is additionally used.SELECTED DRAWING: None

Inventors:

MELANIE TAZIAUX
GLWADYS RAUSIN
MAUD JOST
MARIE MAWET

Application Number:

JP2023108013A

Publication Date:

September 05, 2023

Filing Date:

June 30, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ESTETRA SRL

International Classes:

A61K31/565; A61K31/55; A61K31/57; A61K31/585; A61P5/30; A61P15/12

Attorney, Agent or Firm:

Takashi Shoji

Previous Patent: Gene therapy to treat mucopolysaccharidosis type I

Next Patent: Compounds and their use for alleviating symptoms associated with menopause